Antioxidant tested to calm early psychosis signs
NCT ID NCT05142735
Summary
This study is testing whether a supplement called N-acetylcysteine (NAC) can reduce early warning signs of schizophrenia in young people at high risk. Ninety participants will take either NAC or a placebo pill daily for 8 weeks to see if it improves their symptoms and related brain activity. The goal is to find a safer, well-tolerated option to help manage these early symptoms and potentially prevent them from getting worse.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRODROMAL SCHIZOPHRENIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Centre for Addiction and Mental Health
RECRUITINGToronto, Ontario, M5T 1R8, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.